Novavax (NVAX) Misses Q3 EPS by 3c

Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $6.53 million versus the consensus estimate of $10.59 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c